M I Weintraub, M H Van Woert. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh: See more » Brain/drug effectsBrain/metabolismDihydroxyphenylalanine/administration & dosageDihydroxyphenylalanine/pharmacologyDihydroxyphenylalanine/therapeutic useDopamine/metabolismDrug HypersensitivityFemaleHandwritingHumansInjections, IntravenousMaleMiddle AgedMovement Disorders/drug therapyNeurologic ManifestationsNeurons/drug effectsParasympatholytics/administration & dosageParasympatholytics/therapeutic useParasympathomimetics/pharmacologyParkinson Disease/drug therapyParkinson Disease/metabolismPhysostigmine/antagonists & inhibitorsPhysostigmine/pharmacologyStimulation, ChemicalTrihexyphenidyl/pharmacologyTropanes/pharmacology
Substances: See more » ParasympatholyticsParasympathomimeticsTropanesDihydroxyphenylalanineTrihexyphenidylPhysostigmineDopamine
Year: 1971 PMID: 5540479 DOI: 10.1056/NEJM197102252840804
Source DB: PubMed Journal: N Engl J Med ISSN: 0028-4793 Impact factor: 91.245